Adhi Veda Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.55 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -55.10%
- Profit Growth 21.54%
- Ebitda 18.67%
- Net Worth -111.82%
- Total Assets 15.46%
About Adhi Veda Pharmaceutical
Adhi Veda Pharmaceutical Private Limited (AVPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 February 2021 (Three years and 11 months 5 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.55 M, as per Ministry of Corporate Affairs (MCA) records.
Anoop Anil and Reshma Hareendran serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299KL2021PTC067721
-
Company No.
067721
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Feb 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Adhi Veda Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anoop Anil
|
Director | 26-Feb-2021 | Current |
|
Reshma Hareendran
|
Director | 26-Feb-2021 | Current |
Financial Performance of Adhi Veda Pharmaceutical.
Adhi Veda Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 55.1% decrease. The company also saw a substantial improvement in profitability, with a 21.54% increase in profit. The company's net worth observed a substantial decline by a decrease of 111.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adhi Veda Pharmaceutical?
In 2023, Adhi Veda Pharmaceutical had a public holding of 9.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adhi Veda Pharmaceutical?
Adhi Veda Pharmaceutical has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adhi Veda Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adhi Veda Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.